Mutations in a Gene Linked to Drug Resistance in Malaria Parasites
Author Information
Author(s): Hunt Paul, Afonso Ana, Creasey Alison, Culleton Richard, Sidhu Amar Bir Singh, Logan John, Valderramos Stephanie G, McNae Iain, Cheesman Sandra, do Rosario Virgilio, Carter Richard, Fidock David A, Cravo Pedro
Primary Institution: Institute for Immunology and Infection Research, School of Biological Sciences, University of Edinburgh
Hypothesis
What resistance mechanisms are possible and what are their genetic bases?
Conclusion
The study identified two mutations in a gene encoding a deubiquitinating enzyme that may contribute to drug resistance in malaria parasites.
Supporting Evidence
- Two mutations in the UBP-1 gene were identified in chloroquine-resistant clones.
- Mutations occurred independently under drug selection with chloroquine or artesunate.
- Each mutation maps to a critical residue in a homologous human deubiquitinating protein structure.
Takeaway
Scientists found changes in a specific gene that help malaria parasites resist drugs like artemisinin and chloroquine, which are used to treat malaria.
Methodology
The study used genetic crosses and Linkage Group Selection to analyze mutations in malaria parasites under drug selection.
Limitations
The study does not provide direct evidence linking UBP-1 mutations to artemisinin resistance.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website